Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma

Future Oncology, Ahead of Print.

Source: Future Oncology - October 9, 2020 Category: Cancer & Oncology Authors: Valeria Merz Camilla Zecchetto Davide Melisi Source Type: research